Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Mostra altre versioni (1)

Primaquine (PQ) kills Plasmodium vivax hypnozoites but can cause severe hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. We conducted two systematic reviews. The first used data from clinical trials to determine the variety of definitions and frequency of hematological...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Yilma, D, Groves, ES, Brito-Sousa, JD, Monteiro, WM, Chu, C, Thriemer, K, Commons, RJ, Lacerda, MVG, Price, RN, Douglas, NM
Natura:	Journal article
Lingua:	English
Pubblicazione:	American Society of Tropical Medicine and Hygiene 2023

Documenti analoghi

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
di: Yilma, D, et al.
Pubblicazione: (2021)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
di: Price, RN, et al.
Pubblicazione: (2018)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
di: John, G, et al.
Pubblicazione: (2012)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
di: Watson, JA, et al.
Pubblicazione: (2022)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
di: Watson, J, et al.
Pubblicazione: (2018)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
di: Abla, N, et al.
Pubblicazione: (2024)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
di: Watson, JA, et al.
Pubblicazione: (2024)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
di: Taylor, WRJ, et al.
Pubblicazione: (2023)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
di: Taylor, WR, et al.
Pubblicazione: (2021)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
di: Rahmalia, A, et al.
Pubblicazione: (2019)

Primaquine-induced severe hemolysis in the absence of concomitant malaria: effects on G6PD activity and renal function
di: Douglas, NM, et al.
Pubblicazione: (2022)

Primaquine for plasmodium vivax malaria treatment – authors' reply
di: Price, RN, et al.
Pubblicazione: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
di: Setyadi, A, et al.
Pubblicazione: (2019)

Progress towards safer and more effective radical cure of Plasmodium vivax
di: Price, RN
Pubblicazione: (2024)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
di: Poespoprodjo, JR, et al.
Pubblicazione: (2021)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
di: Taylor, WRJ, et al.
Pubblicazione: (2019)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
di: Pukrittayakamee, S, et al.
Pubblicazione: (2010)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
di: Commons, RJ, et al.
Pubblicazione: (2020)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
di: Llanos-Cuentas, A, et al.
Pubblicazione: (2019)

Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.
di: Fryauff, D, et al.
Pubblicazione: (1997)

Evidence uptake is only part of the process: stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria
di: Ruwanpura, VSH, et al.
Pubblicazione: (2024)

Improving the radical cure of Plasmodium vivax malaria.
di: Price, R
Pubblicazione: (2014)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
di: Thriemer, K, et al.
Pubblicazione: (2020)

Plasmodium vivax in the era of the shrinking P. falciparum map
di: Price, RN, et al.
Pubblicazione: (2020)

A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
di: Sadhewa, A, et al.
Pubblicazione: (2023)

Strategies for improving radical cure in P. vivax malaria
di: John, G
Pubblicazione: (2012)

Declining burden of plasmodium vivax in a population in Northwestern Thailand from 1995 to 2016 before comprehensive primaquine prescription for radical cure
di: Chu, CS, et al.
Pubblicazione: (2019)

Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
di: Ruwanpura, VSH, et al.
Pubblicazione: (2021)

Primaquine induced haemolysis in G6PD heterozygous females treated for the radical cure of Plasmodium vivax malaria: a nested cohort study
di: Chu, C, et al.
Pubblicazione: (2017)

Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
di: Abreha, T, et al.
Pubblicazione: (2015)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
di: Rahmalia, A, et al.
Pubblicazione: (2023)

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
di: Thriemer, K, et al.
Pubblicazione: (2022)

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
di: Fadilah, I, et al.
Pubblicazione: (2024)

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
di: Commons, RJ, et al.
Pubblicazione: (2023)

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
di: Mehdipour, P, et al.
Pubblicazione: (2023)

Single-dose radical cure of Plasmodium vivax: a step closer.
di: Price, R, et al.
Pubblicazione: (2014)

Single-dose radical cure of Plasmodium vivax: A step closer
di: Price, R, et al.
Pubblicazione: (2014)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
di: Rajasekhar, M, et al.
Pubblicazione: (2023)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
di: Poespoprodjo, Jeanne Rini, et al.
Pubblicazione: (2022)

Challenges for achieving safe and effective radical cure of P. vivax – a round table discussion of the APMEN Vivax Working Group
di: Thriemer, K, et al.
Pubblicazione: (2017)